CR Bard Voluntarily Recalls XenMatrix Surgical Graft Product

Date : 01/11/2011 @ 10:04AM
Source : Dow Jones News
Stock : C.R. Bard, Inc. (BCR)
Quote : 303.71  0.2 (0.07%) @ 4:02PM

CR Bard Voluntarily Recalls XenMatrix Surgical Graft Product

Bard C R (NYSE:BCR)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Bard C R Charts.

C.R. Bard Inc. (BCR) disclosed Tuesday that its Davol Inc. subsidiary has voluntarily recalled a surgical-graft product called XenMatrix that is used in hernia and abdominal wall repair.

The medical-device maker said its previously issued guidance for the fourth quarter last year and full-year this year remains unchanged despite the recall.

The company disclosed the event in a brief filing with the Securities and Exchange Commission, where it said the recall started on Friday. It did not describe a reason for the recall, and a spokesman could not be reached for immediate comment on the matter.

Bard's shares traded up 26 cents to $91.31 early Tuesday.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

 
 



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.